Kit Mutation (D816V) for Mastocytosis
C-kit Mutation , U of M: D816V, EPIC: LAB7101, SOFT: XCKIG
Specimen Collection Criteria
Collect (preferred specimen): Blood or bone marrow in one Lavender-top EDTA tube. (Min: 0.5 mL)
Invert several times to mix blood or bone marrow.
Physician Office/Drawsite Specimen Preparation
Do not centrifuge. Maintain specimen in original collection tube, room temperature (20-26°C or 68-78.8°F) prior to transport.
Preparation for Courier Transport
Transport: 5.0 mL Blood or 3.0 mL bone marrow, room temperature (20-26°C or 68-78.8°F) in original collection tube. (Min: 0.5 mL)
- Specimens that are clotted or grossly hemolyzed.
- Specimens not collected and processed as indicated.
Monday - Friday.
Results available in 5-8 days.
Allel-Specific Oligonucleotide Polymerase Chain Reaction (PCR) with capillary electrophoresis detection.
Detection of a mutation at the 816 codon is included as one of the minor diagnostic criteria for systemic mastocytosis in the World Health Organization classification system for hematopoietic neoplasms and is also of therapeutic relevance as it confers resistance to imatnib, a drug commonly used to treat CMPDs. The mutation has not been reported in normal tissues.
Systemic mastocytosis is a hematopoetic neoplasm that can be included in the general category of chronic myeloproliferative disorders (CMPDs. These neoplasms are characterized by excessive proliferation of one or more myeloid lineages, with cells filling the bone marrow and populating other hematopoetic sites. In systemic mastocytosis, mast cell proliferation is the defining feature, although other myeloid lineages and B-cells are frequently part of the neoplastic clone.
U of M: D816V, EPIC: LAB7101, SOFT: XCKIG
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.
This directory currently reflects information only for specimens collected and/or processed at the
Farmington Hills, Grosse Pointe, Royal Oak, and Troy campuses.